Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (MXMX/a/2011/007854) METHODS FOR TREATING ACUTE MYOCARDIAL INFARCTIONS AND ASSOCIATED DISORDERS

Office : Mexico
Application Number: MX/a/2011/007854 Application Date: 25.07.2011
Publication Number: MX/a/2011/007854 Publication Date: 12.09.2011
Publication Kind : A
Prior PCT appl.: Application Number:US2010022112 ; Publication Number:2010085805 Click to see the data
IPC:
A61P 9/10
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9
Drugs for disorders of the cardiovascular system
10
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
INTERMUNE, INC.
Inventors: KARL KOSSEN
JEFF OLGIN
Agents: DAVID PASCUAL GARCIA*
Priority Data: 61/147,340 26.01.2009 US
Title: (EN) METHODS FOR TREATING ACUTE MYOCARDIAL INFARCTIONS AND ASSOCIATED DISORDERS
(ES) METODOS PARA TRATAR INFARTOS AGUDOS AL MIOCARDIO Y TRASTORNOS RELACIONADOS
Abstract:
(EN) The invention relates to methods of treating patients who have suffered an acute myocardial infarction (AMI) with a therapeutic that has anti-fibrotic effects, for example, pirfenidone and analogs thereof The method of treating a patient who has suffered an acute myocardial infarction may include administering to the patient a therapeutically effective dose of a therapeutic having an anti-fibrotic effect, wherein optionally the treatment is initiated at a time period about 1 to 42 days after suffering the AMI, and optionally continues for up to 3 to 6 months
(ES) La invención se refiere a métodos para tratar a pacientes que han sufrido un infarto agudo al miocardio (IMA) con un compuesto terapéutico que tiene efectos antifibróticos, por ejemplo, la pirfenidona y sus análogos. El método para tratar al paciente que ha sufrido un infarto agudo al miocardio puede incluir administrarle al paciente una dosis terapéuticamente efectiva de un compuesto terapéutico que tiene un efecto antifibrótico, en donde el tratamiento opcionalmente se inicia entre 1 y 42 días después de ocurrido el IAM y opcionalmente se prolonga durante hasta 3 y 6 meses.
Also published as:
NZ593583UAa201109441IL213526SG172981EP2389227JP2012515800
CN102292124CA2747251MX2011007854KR1020110114684TN2011000364BRPI1006979
AU2010206543ID2012/00475MYPI 2011003334IN5985/DELNP/2011WO/2010/085805